NUtech Ventures has developed an innovative universal influenza vaccine that aims to tackle one of the world’s most pressing health challenges: the constant evolution of the influenza virus. Traditional flu vaccines must be updated annually to match the specific strains circulating each season, but NUtech’s breakthrough focuses on creating a more robust, long-lasting solution. By utilizing polypeptides with high sequence identity—90% or greater—to known viral proteins, this vaccine is designed to offer broad protection against multiple strains, including those with significant genetic differences.

This cutting-edge vaccine works by incorporating highly conserved regions of viral proteins, ensuring that even as the influenza virus mutates, the immune response triggered by the vaccine remains effective. Moreover, the invention includes multiple delivery options, such as viral vectors and nanoparticles, enhancing the vaccine’s adaptability across different methods of administration. With the potential to protect both humans and swine, this technology offers a dual advantage, addressing human flu outbreaks while minimizing economic losses in the swine industry caused by influenza.

The implications of this research are profound. If successful, NUtech Ventures’ universal influenza vaccine could eliminate the need for annual flu shots, reduce the global economic burden of flu outbreaks, and better prepare the world for future pandemics. By targeting a wide array of viral sub-types, this vaccine represents a significant leap forward in the fight against influenza.

Are you developing new technology for an existing application? Did you know your development work could be eligible for the R&D Tax Credit and you can receive up to 14% back on your expenses? Even if your development isn’t successful your work may still qualify for R&D credits (i.e. you don’t need to have a patent to qualify). To find out more, please contact a Swanson Reed R&D Specialist today or check out our free online eligibility test.

Who We Are:

Swanson Reed is one of the U.S.’ largest Specialist R&D tax advisory firms. We manage all facets of the R&D tax credit program, from claim preparation and audit compliance to claim disputes.

Swanson Reed regularly hosts free webinars and provides free IRS CE and CPE credits for CPAs. For more information please visit us at www.swansonreed.com/webinars or contact your usual Swanson Reed representative.

R&D Tax Credit Preparation Services

Swanson Reed is one of the only companies in the United States to exclusively focus on R&D tax credit preparation. Swanson Reed provides state and federal R&D tax credit preparation and audit services to all 50 states.

If you have any questions or need further assistance, please call or email our CEO, Damian Smyth on (800) 986-4725.
Feel free to book a quick teleconference with one of our national R&D tax credit specialists at a time that is convenient for you.

R&D Tax Credit Audit Advisory Services

creditARMOR is a sophisticated R&D tax credit insurance and AI-driven risk management platform. It mitigates audit exposure by covering defense expenses, including CPA, tax attorney, and specialist consultant fees—delivering robust, compliant support for R&D credit claims. Click here for more information about R&D tax credit management and implementation.

Our Fees

Swanson Reed offers R&D tax credit preparation and audit services at our hourly rates of between $195 – $395 per hour. We are also able offer fixed fees and success fees in special circumstances. Learn more at https://www.swansonreed.com/about-us/research-tax-credit-consulting/our-fees/